MDL | - |
---|---|
Molecular Weight | 352.47 |
Molecular Formula | C22H28N2O2 |
SMILES | O=C(C1=CC=C(NC2CCCCC2)C(NCC3=CC=CC=C3)=C1)OCC |
SRS11-92, a Ferrostatin-1 (Fer-1) analogue, is a potent ferroptosis inhibitor. SRS11-92 inhibits ferroptotic cell death induced by Erastin in HT-1080 human fibrosarcoma cells (EC 50 =6 nM) [1] .
SRS11-92 fully protects oligodendrocytes (OLs) from cystine deprivation when tested at 100 nM. SRS11-92 rescues primary human fibroblasts from death induced by frataxin knock-down [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
SRS11-92, used at 500 nM, is efficacious in protecting human and mouse cellular models of Friedreich ataxia (FRDA) treated with ferric ammonium citrate (FAC) and an inhibitor of glutathione synthesis (BSO), whereas caspase-3 inhibitors fail to show significant biological activity [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Powder
Room temperature in continental US; may vary elsewhere.
4°C, protect from light
* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
DMSO : 250 mg/mL ( 709.28 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.8371 mL | 14.1856 mL | 28.3712 mL |
5 mM | 0.5674 mL | 2.8371 mL | 5.6742 mL |
10 mM | 0.2837 mL | 1.4186 mL | 2.8371 mL |